Company profile NERV
After 39 days of this quarter the interest is at 21.0. Based on that we can calculate that during remaining 52 days it will total up to 49.0. Minerva Neurosciences expected interest is significantly higher compared to previous quarter (+44.1%) and same quarter last year (+96.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 56 inf% QoQ | 60 7.1% QoQ | 27 -55.0% QoQ |
| 2020 | 31 inf% YoY 14.8% QoQ | 233 316.1% YoY 651.6% QoQ | 112 86.7% YoY -51.9% QoQ | 47 74.1% YoY -58.0% QoQ |
| 2021 | 28 -9.7% YoY -40.4% QoQ | 35 -85.0% YoY 25.0% QoQ | 24 -78.6% YoY -31.4% QoQ | 18 -61.7% YoY -25.0% QoQ |
| 2022 | 21 -25.0% YoY 16.7% QoQ | 11 -68.6% YoY -47.6% QoQ | 77 220.8% YoY 600.0% QoQ | 25 38.9% YoY -67.5% QoQ |
| 2023 | 25 19.0% YoY 0.0% QoQ | 47 327.3% YoY 88.0% QoQ | 21 -72.7% YoY -55.3% QoQ | 34 36.0% YoY 61.9% QoQ |
| 2024 | 21 -16.0% YoY -38.2% QoQ | - | - | - |
The average 5 years interest of Minerva Neurosciences was 3.65 per week. The last year interest of Minerva Neurosciences compared to the last 5 years has changed by -27.95%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -14.61%.
After 39 days of this quarter the interest is at 41.0. Based on that we can calculate that during remaining 52 days it will total up to 96.0. Minerva Neurosciences stock expected interest is significantly higher compared to previous quarter (+380.0%) and same quarter last year (+118.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 12 | 141 1075.0% QoQ | 95 -32.6% QoQ | 62 -34.7% QoQ |
| 2020 | 32 166.7% YoY -48.4% QoQ | 322 128.4% YoY 906.2% QoQ | 187 96.8% YoY -41.9% QoQ | 45 -27.4% YoY -75.9% QoQ |
| 2021 | 107 234.4% YoY 137.8% QoQ | 44 -86.3% YoY -58.9% QoQ | 38 -79.7% YoY -13.6% QoQ | 105 133.3% YoY 176.3% QoQ |
| 2022 | 70 -34.6% YoY -33.3% QoQ | 58 31.8% YoY -17.1% QoQ | 103 171.1% YoY 77.6% QoQ | 79 -24.8% YoY -23.3% QoQ |
| 2023 | 44 -37.1% YoY -44.3% QoQ | 74 27.6% YoY 68.2% QoQ | 50 -51.5% YoY -32.4% QoQ | 20 -74.7% YoY -60.0% QoQ |
| 2024 | 41 -6.8% YoY 105.0% QoQ | - | - | - |
The average 5 years interest of Minerva Neurosciences stock was 6.62 per week. The last year interest of Minerva Neurosciences stock compared to the last 5 years has changed by -38.07%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -35.74%.
After 39 days of this quarter the interest is at 26.0. Based on that we can calculate that during remaining 52 days it will total up to 61.0. roluperidone expected interest is significantly lower compared to same quarter last year (-59.6%) but higher than previous quarter (+165.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 30 | 110 266.7% QoQ | 78 -29.1% QoQ | 87 11.5% QoQ |
| 2020 | 59 96.7% YoY -32.2% QoQ | 212 92.7% YoY 259.3% QoQ | 95 21.8% YoY -55.2% QoQ | 160 83.9% YoY 68.4% QoQ |
| 2021 | 96 62.7% YoY -40.0% QoQ | 45 -78.8% YoY -53.1% QoQ | 35 -63.2% YoY -22.2% QoQ | 132 -17.5% YoY 277.1% QoQ |
| 2022 | 49 -49.0% YoY -62.9% QoQ | 212 371.1% YoY 332.7% QoQ | 63 80.0% YoY -70.3% QoQ | 150 13.6% YoY 138.1% QoQ |
| 2023 | 151 208.2% YoY 0.7% QoQ | 60 -71.7% YoY -60.3% QoQ | 101 60.3% YoY 68.3% QoQ | 23 -84.7% YoY -77.2% QoQ |
| 2024 | 26 -82.8% YoY 13.0% QoQ | - | - | - |
The average 5 years interest of roluperidone was 7.56 per week. The last year interest of roluperidone compared to the last 5 years has changed by -46.56%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -31.18%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. MIN-101 expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 37 | 24 -35.1% QoQ | 32 33.3% QoQ | 36 12.5% QoQ |
| 2020 | 53 43.2% YoY 47.2% QoQ | 90 275.0% YoY 69.8% QoQ | 120 275.0% YoY 33.3% QoQ | 99 175.0% YoY -17.5% QoQ |
| 2021 | 55 3.8% YoY -44.4% QoQ | 153 70.0% YoY 178.2% QoQ | 133 10.8% YoY -13.1% QoQ | 27 -72.7% YoY -79.7% QoQ |
| 2022 | 46 -16.4% YoY 70.4% QoQ | 89 -41.8% YoY 93.5% QoQ | 156 17.3% YoY 75.3% QoQ | 55 103.7% YoY -64.7% QoQ |
| 2023 | 58 26.1% YoY 5.5% QoQ | 122 37.1% YoY 110.3% QoQ | 102 -34.6% YoY -16.4% QoQ | 125 127.3% YoY 22.5% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of MIN-101 was 6.18 per week. The last year interest of MIN-101 compared to the last 5 years has changed by 13.92%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 122.08%.
There is not enough data for MIN-301 to provide analysis
There is not enough data for MIN-301 to provide correlation calculation
There is not enough data for MIN-301 to provide analysis
There is not enough data for neuregulin-1b1 protein to provide analysis
There is not enough data for neuregulin-1b1 protein to provide correlation calculation
There is not enough data for neuregulin-1b1 protein to provide analysis
After 34 days of this quarter the interest is at 93.0. Based on that we can calculate that during remaining 58 days it will total up to 252.0. central nervous system diseases expected interest is significantly lower compared to same quarter last year (-49.4%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 0 |
| 2019 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 |
| 2022 | 42 inf% YoY inf% QoQ | 460 inf% YoY 995.2% QoQ | 296 inf% YoY -35.7% QoQ | 498 inf% YoY 68.2% QoQ |
| 2023 | 477 1035.7% YoY -4.2% QoQ | 403 -12.4% YoY -15.5% QoQ | 303 2.4% YoY -24.8% QoQ | 93 -81.3% YoY -69.3% QoQ |
The average 5 years interest of central nervous system diseases was 9.89 per week. The last year interest of central nervous system diseases compared to the last 5 years has changed by 210.11%. This is something to be checked. This didn't exist 5 years ago.
There is not enough data for negative symptoms in schizophrenia to provide analysis
There is not enough data for negative symptoms in schizophrenia to provide correlation calculation
There is not enough data for negative symptoms in schizophrenia to provide analysis
There is not enough data for Parkinson's disease to provide analysis
There is not enough data for Parkinson's disease to provide correlation calculation
There is not enough data for Parkinson's disease to provide analysis
After 39 days of this quarter the interest is at 269.0. Based on that we can calculate that during remaining 52 days it will total up to 628.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 50 | 373 646.0% QoQ | 215 -42.4% QoQ | 415 93.0% QoQ |
| 2020 | 216 332.0% YoY -48.0% QoQ | 196 -47.5% YoY -9.3% QoQ | 287 33.5% YoY 46.4% QoQ | 424 2.2% YoY 47.7% QoQ |
| 2021 | 327 51.4% YoY -22.9% QoQ | 184 -6.1% YoY -43.7% QoQ | 229 -20.2% YoY 24.5% QoQ | 340 -19.8% YoY 48.5% QoQ |
| 2022 | 429 31.2% YoY 26.2% QoQ | 306 66.3% YoY -28.7% QoQ | 408 78.2% YoY 33.3% QoQ | 415 22.1% YoY 1.7% QoQ |
| 2023 | 573 33.6% YoY 38.1% QoQ | 551 80.1% YoY -3.8% QoQ | 357 -12.5% YoY -35.2% QoQ | 650 56.6% YoY 82.1% QoQ |
| 2024 | 269 -53.1% YoY -58.6% QoQ | - | - | - |
The average 5 years interest of neurodegenerative disorders was 27.64 per week. The last year interest of neurodegenerative disorders compared to the last 5 years has changed by 46.38%. The interest for neurodegenerative disorders is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 89.07%.
After 39 days of this quarter the interest is at 51.0. Based on that we can calculate that during remaining 52 days it will total up to 119.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 170 | 235 38.2% QoQ | 153 -34.9% QoQ | 116 -24.2% QoQ |
| 2020 | 234 37.6% YoY 101.7% QoQ | 212 -9.8% YoY -9.4% QoQ | 255 66.7% YoY 20.3% QoQ | 226 94.8% YoY -11.4% QoQ |
| 2021 | 204 -12.8% YoY -9.7% QoQ | 52 -75.5% YoY -74.5% QoQ | 147 -42.4% YoY 182.7% QoQ | 38 -83.2% YoY -74.1% QoQ |
| 2022 | 224 9.8% YoY 489.5% QoQ | 139 167.3% YoY -37.9% QoQ | 126 -14.3% YoY -9.4% QoQ | 124 226.3% YoY -1.6% QoQ |
| 2023 | 194 -13.4% YoY 56.5% QoQ | 93 -33.1% YoY -52.1% QoQ | 91 -27.8% YoY -2.2% QoQ | 121 -2.4% YoY 33.0% QoQ |
| 2024 | 51 -73.7% YoY -57.9% QoQ | - | - | - |
The average 5 years interest of Mitsubishi Tanabe Pharma was 12.28 per week. The last year interest of Mitsubishi Tanabe Pharma compared to the last 5 years has changed by -25.73%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -38.5%.
There is not enough data for Cyrenaic Pharmaceuticals. to provide analysis
There is not enough data for Cyrenaic Pharmaceuticals. to provide correlation calculation
There is not enough data for Cyrenaic Pharmaceuticals. to provide analysis